FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults Dermatology Times
Finance, IT & News
FDA Approves Pritelivir for Refractory Mucocutaneous HSV in Immunocompromised Adults Dermatology Times
FDA clears Surrozen's IND for DME therapy Glance by Eyes On Eyecare
FDA approves aortic stent graft from Gore for FEVAR and BEVAR Cardiovascular Business
FDA approval of Gazyva offers new option for pediatric INS Contemporary Pediatrics
FDA Approves First Treatment for BCG-Unresponsive Bladder Cancer The American Journal of Managed Care